These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23103817)

  • 1. [Inflammatory cytokines in rheumatoid arthritis].
    Murakami M; Nishimoto N
    Clin Calcium; 2012 Nov; 22(11):1737-46. PubMed ID: 23103817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [IL-6 inhibitors prevent bone loss and cartilage degeneration in rheumatoid arthritis].
    Murakami M; Nishimoto N
    Clin Calcium; 2015 Dec; 25(12):1851-7. PubMed ID: 26608861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rheumatoid arthritis and cytokines].
    Kaneko S; Kondo Y; Yokosawa M; Sumida T
    Nihon Rinsho; 2016 Jun; 74(6):913-8. PubMed ID: 27311178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rheumatoid arthritis, inflammation, and atherosclerosis].
    Hürlimann D; Enseleit F; Ruschitzka F
    Herz; 2004 Dec; 29(8):760-8. PubMed ID: 15599672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. META060 inhibits osteoclastogenesis and matrix metalloproteinases in vitro and reduces bone and cartilage degradation in a mouse model of rheumatoid arthritis.
    Konda VR; Desai A; Darland G; Bland JS; Tripp ML
    Arthritis Rheum; 2010 Jun; 62(6):1683-92. PubMed ID: 20201075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine-mediated bone destruction in rheumatoid arthritis.
    Jung SM; Kim KW; Yang CW; Park SH; Ju JH
    J Immunol Res; 2014; 2014():263625. PubMed ID: 25295284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of cytokines, vascular endothelial growth factor, matrix metalloproteinases, and tissue inhibitor of metalloproteinases 1 by tenosynovium demonstrates its potential for tendon destruction in rheumatoid arthritis.
    Jain A; Nanchahal J; Troeberg L; Green P; Brennan F
    Arthritis Rheum; 2001 Aug; 44(8):1754-60. PubMed ID: 11508425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early structural changes in cartilage and bone are required for the attachment and invasion of inflamed synovial tissue during destructive inflammatory arthritis.
    Korb-Pap A; Stratis A; Mühlenberg K; Niederreiter B; Hayer S; Echtermeyer F; Stange R; Zwerina J; Pap T; Pavenstädt H; Schett G; Smolen JS; Redlich K
    Ann Rheum Dis; 2012 Jun; 71(6):1004-11. PubMed ID: 22258493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of interleukin-17 in mediating joint destruction in rheumatoid arthritis.
    Li X; Yuan FL; Lu WG; Zhao YQ; Li CW; Li JP; Xu RS
    Biochem Biophys Res Commun; 2010 Jun; 397(2):131-5. PubMed ID: 20513356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Osteoimmunology-overview].
    Okamoto K; Takayanagi H
    Clin Calcium; 2012 Nov; 22(11):1641-9. PubMed ID: 23103807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of inflammation and joint destruction in rheumatoid arthritis may require a concerted action of Th2 cytokines.
    van Roon JA; Bijlsma JW; Lafeber FP
    Curr Opin Investig Drugs; 2002 Jul; 3(7):1011-6. PubMed ID: 12186260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of bone and cartilage destruction in rheumatoid arthritis.
    Goldring SR
    Rheumatology (Oxford); 2003 May; 42 Suppl 2():ii11-6. PubMed ID: 12817090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor blockade differentially affects innate inflammatory and Th17 cytokines in rheumatoid arthritis.
    Zivojinovic SM; Pejnovic NN; Sefik-Bukilica MN; Kovacevic LV; Soldatovic II; Damjanov NS
    J Rheumatol; 2012 Jan; 39(1):18-21. PubMed ID: 22133625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bone and cartilage destruction in rheumatoid arthritis].
    Komatsu N; Takayanagi H
    Clin Calcium; 2012 Feb; 22(2):179-85. PubMed ID: 22298070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune arthritis: the interface between the immune system and joints.
    Komatsu N; Takayanagi H
    Adv Immunol; 2012; 115():45-71. PubMed ID: 22608255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammalian target of rapamycin signaling is crucial for joint destruction in experimental arthritis and is activated in osteoclasts from patients with rheumatoid arthritis.
    Cejka D; Hayer S; Niederreiter B; Sieghart W; Fuereder T; Zwerina J; Schett G
    Arthritis Rheum; 2010 Aug; 62(8):2294-302. PubMed ID: 20506288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph draining from foot joints in rheumatoid arthritis provides insight into local cytokine and chemokine production and transport to lymph nodes.
    Olszewski WL; Pazdur J; Kubasiewicz E; Zaleska M; Cooke CJ; Miller NE
    Arthritis Rheum; 2001 Mar; 44(3):541-9. PubMed ID: 11263768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraarticular injection of platelet-rich plasma reduces inflammation in a pig model of rheumatoid arthritis of the knee joint.
    Lippross S; Moeller B; Haas H; Tohidnezhad M; Steubesand N; Wruck CJ; Kurz B; Seekamp A; Pufe T; Varoga D
    Arthritis Rheum; 2011 Nov; 63(11):3344-53. PubMed ID: 21769848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheumatoid arthritis: from autoimmunity to synovitis and joint destruction.
    Boissier MC; Semerano L; Challal S; Saidenberg-Kermanac'h N; Falgarone G
    J Autoimmun; 2012 Sep; 39(3):222-8. PubMed ID: 22704962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.